Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-15
2005-03-15
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S258100, C514S264100, C514S264110, C514S265100, C514S266200, C544S253000, C544S279000, C544S284000, C544S293000
Reexamination Certificate
active
06867201
ABSTRACT:
The invention relates to compounds of the formula 1and to pharmaceutically acceptable salts and solvates thereof, wherein A, X, R1, R3and R4are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
REFERENCES:
patent: 5256781 (1993-10-01), Primeau et al.
patent: 5283242 (1994-02-01), Ellingboe
patent: 5360809 (1994-11-01), Axelsson
patent: 5736534 (1998-04-01), Arnold
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5866572 (1999-02-01), Barker et al.
patent: 9834259 (2000-01-01), Kath et al.
patent: 6344459 (2002-02-01), Bridges et al.
patent: 2225366 (1998-06-01), None
patent: 0414386 (1991-02-01), None
patent: 0520722 (1992-12-01), None
patent: 0566226 (1993-10-01), None
patent: 0602851 (1994-06-01), None
patent: 0635498 (1995-01-01), None
patent: 0635507 (1995-01-01), None
patent: 0837063 (1998-04-01), None
patent: 0882717 (1998-12-01), None
patent: WO9220642 (1992-11-01), None
patent: WO9307146 (1993-04-01), None
patent: WO9515758 (1995-06-01), None
patent: WO9519774 (1995-07-01), None
patent: WO9523141 (1995-08-01), None
patent: 9607657 (1996-03-01), None
patent: WO9609294 (1996-03-01), None
patent: WO9616960 (1996-06-01), None
patent: WO9628430 (1996-09-01), None
patent: WO9630347 (1996-10-01), None
patent: WO9640142 (1996-12-01), None
patent: WO9721701 (1997-06-01), None
patent: WO9722596 (1997-06-01), None
patent: WO9730034 (1997-08-01), None
patent: WO9730044 (1997-08-01), None
patent: 9732880 (1997-09-01), None
patent: 9732882 (1997-09-01), None
patent: 9738983 (1997-10-01), None
patent: WO9802434 (1998-01-01), None
patent: WO9802437 (1998-01-01), None
patent: WO9802438 (1998-01-01), None
Chemical Abstracts DN 127:278208, also cited as WO 9732882.*
Chemical Abstract DN 127:278206, also cited as WO 9732880.*
Chemical Abstract DN 125:33669, also cited as WO 96078657.*
Spada et al., “Small Molecule Inhibitors of Tyrosine Kinase Activity,”Expert Opinion on Therapeutic Patents, GB, Ashley Publications, vol. 5, No. 8, Jan. 1, 1995.
Craciunescu et al., “Study of the “in vivo” Dueal (Antitumor and Trypanocidal) Pharmacological Effects Displayed By Dimeric and Neutral New Complexes of Iridium (II) and Rhodium (II) With Classical Antimalarial Drugs,” An. R. Acad. Farm., 1991, 57(1), 15-35.
Nomoto et al., “Studies on Cardiotonic Agents. VI. Potent Cardiotonic Agent KF15232 With Myofribillar Calcium Sensitizing Effect,” Chem. Pharm. Bull., 1991, 39(4), 900-910.
Bhattacharya Samit Kumar
Cox Eric David
Kath John Charles
Tom Norma Jacqueline
Ancona Pamela C.
Butterfield Garth
Patel Sudhaker B.
Pfizer Inc
Raymond Richard L.
LandOfFree
Heteroaromatic bicyclic derivatives useful as anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaromatic bicyclic derivatives useful as anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaromatic bicyclic derivatives useful as anticancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436057